Back in January we told you about Cephalon’s submission of their sleep disorder drug, Nuvigil, to be approved as a treatment for jet lag by the FDA.  The FDA has completed its review, but they have not approved the application because of questions pertaining to some of the data submitted.  Cephalon is already following up with the FDA to clarify the points in question and we’ll continue to track its progress through the process.

Share

About The Author

Subscribe for Updates and News!

Join our email list to receive the latest in healthy travel news, trends and issues.

You have Successfully Subscribed!

Close